Vaquero J, Arias A, Zurita M, Coca S, Oya S, Morales C
Neurosurgical Department, Puerta de Hierro Clinic, Autonomous University, Madrid, Spain.
Oncol Res. 1992;4(7):275-80.
Using the experimental model of brain tumors induced by ethyl-nitrosourea (ENU), human recombinant interleukin-2 (rIL-2) and tumor necrosis factor-alpha (TNF-alpha) were administered to Wistar rats in early stages of carcinogenesis. The results obtained suggest that IL-2 does not influence the development of nervous system tumors. In contrast, TNF-alpha was capable of modulating the development of ENU-induced tumors, producing a reduction in the number of schwannomas and a delay in the appearance of intraparenchymatous brain tumors.